CNL:NASDAQ, Collective Mining Ltd.

CNL stock overview

Collective Mining Ltd. (CNL:NASDAQ) closed at $12.42 on November 13, 2026, down 2.89% on the day. The stock trades 43.5% below its 52-week high of $21.97 and 27.1% above its 52-week low of $9.77. Over the past year, it lost 21.0%. Collective Mining Ltd. is part of the Miscellaneous sector.

Key figures

Price
$12.42
Day change
-2.89%
Volume
190,764
Average volume
177,528
Market cap
1B+
52-week range
$9.77 – $21.97
50-day average
$12.54
200-day average
$15.08

Price action over the past year

In 188 trading sessions since February 18, 2026, CNL closed higher on 89 days (47%). Its best day was November 3, 2026 (+11.94%) and its worst was September 9, 2026 (-11.45%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CNL news

About Collective Mining Ltd.

Founded by the team that developed and sold Continental Gold Inc. to Zijin Mining for approximately $1.4 billion in enterprise value, Collective is a gold, silver, copper and tungsten exploration company with projects in Caldas, Colombia. The Company's two projects are located directly within an established mining camp with ten fully permitted and operating mines. The Company's flagship project, Guayabales, is anchored by the Apollo system, which hosts a large-scale, bulk-tonnage and high-grade gold-silver-copper-tungsten system. The Company's objectives at the Guayabales Project are to expand the newly discovered high-grade Ramp Zone along strike and to depth, drill test the new outcropping Northern Apollo Oxidized area, drill the recently granted license covering the northwestern extension of the Trap target, and drill a series of greenfield generated targets across the property. Management, insiders, a strategic investor and close family and friends own 45.

Similar stocks

Find more stocks like CNL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.